External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Retina World Congress 2025

-
Coming soon
06:35 PM
Duration 30mins Florida, USA
Indirect Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in DME and nAMD
Papakostas T, Keane P, Holekamp N, Leng T, Siedlecki J, Mar F, Gibson K, Margaron P, Buehrer C, Tabano D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 30mins FORT LAUDERDALE MARRIOTT HARBOR BEACH RESORT
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Vakharia P, Bakall B, Koh A, Souied E, Tan C, Yang M, Patel S, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 30mins FORT LAUDERDALE MARRIOTT HARBOR BEACH RESORT
Faricimab▼ Real-World Data Support Clinical Trial Data in Patients With Treatment-Naïve nAMD: Results From TENAYA/LUCERNE and FARETINA/FARWIDE
Brugger J, Avery R, Haug, S, Souied E, Bonine N, Dayal P, Kotecha A, Margaron P, Yang M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:08 PM
Duration 5mins FORT LAUDERDALE MARRIOTT HARBOR BEACH RESORT
Ultra-Responders to Faricimab▼: ≥ 4-Step Improvement in Diabetic Retinopathy Severity in YOSEMITE/RHINE
Uhr J, Patel S, Klufas M, Warter A, Dagincourt N, Gibson K

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:28 PM
Duration 5mins FORT LAUDERDALE MARRIOTT HARBOR BEACH RESORT
Update on Faricimab▼ for DME: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Starr M, Singer M, Khanani A, Abreu F, Gibson K, Kotak A, Lai T, Pearce I, Schlottmann P, Sim D, Yang Y, Kotecha A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar